Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACARBAZINE vs DACOMITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACARBAZINE vs DACOMITINIB: Safety Overview

Metric DACARBAZINE DACOMITINIB
Total FAERS Reports 5,105 682
Deaths Reported 847 325
Death Rate 16.6% 47.7%
Hospitalizations 1,914 168
Average Patient Age 45.5 yrs 64.0 yrs
% Female Patients 47.8% 52.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Sep 27, 2018
Manufacturer Fresenius Kabi USA, LLC Pfizer Laboratories Div Pfizer Inc
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription